The application for the bivalent vaccine for children between the ages of six months and under six years is expected to be completed later this year, the company said in a tweet.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/q93Bub6
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids
https://ift.tt/JcCtEYe
No comments:
Post a Comment